Moreover, TCGA data also indicated that high RPA3 expression correlated with poor OS and a high recurrence rate in patients with head and neck squamous cell carcinoma (HNSC) after radiotherapy. This evidence concerns the gene RPA3 and head and neck squamous cell carcinoma.